
CEL-SCI fell 80.3% from $6.50 to $1.28, behind the S&P 500's +13.3%. Its worst day was May 4 (−25.9%), and its low came Jun 25 at $0.97.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
CEL-SCI closed at its highest level of the year, 18.0% above where the year started.
+2.1% · S&P 500 +0.5%
EPS of $0.07 was reported on $0.00 revenue.
+10.2% · S&P 500 −0.4%
Story events cover the past 12 months · Times ET
CEL-SCI shares rose 21.9%, while the S&P 500 rose 0.5%.
+21.9% · S&P 500 +0.5%
EPS of $-0.68 was reported on $0.00 revenue.
+8.4% · S&P 500 +0.5%
CEL-SCI shares rose 24.5%, while the S&P 500 rose 0.5%.
+24.5%, the year's best day · S&P 500 +0.5%
CEL-SCI shares fell 25.9%, while the S&P 500 fell 0.4%.
−25.9%, the year's worst day · S&P 500 −0.4%
EPS of $-0.67 was reported on $0.00 revenue.
+20.3% · S&P 500 −0.1%
CEL-SCI closed at its lowest level of the year, 85.0% below where the year started.
−2.1% · S&P 500 +0.1%
EPS of $-0.47 was reported on $0.00 revenue.
+0.6% · S&P 500 −0.5%
CEL-SCI shares fell 22.3%, while the S&P 500 fell 0.2%.
−22.3% · S&P 500 −0.2%
Where it ended: a close of $1.28 on Nov 13, 2026. Up next: Q4 2026 earnings on Nov 27, 2026.
Nothing in the past 12 months.
All CVM analyst actionsNothing in the past 12 months.
All CVM dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CVM and SPY from Benzinga historical bars. Not investment advice.